drugset / Trial / NCT05426031
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare two different dosing strategies of a drug named protamine.
Timeline
- Start
- 2022-06-28
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Protamine Sulfate | Unknown | 1 mg | Intravenous |
| Subject | Protamine Sulfate | Unknown | 250 mg | Intravenous |